Genomic aberrations in circulating tumor DNA (ctDNA) and clinical outcomes from [Lu-177] Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC)

CANCER RESEARCH(2023)

引用 0|浏览5
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要